[PDF] Top 20 The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.

... that the improved response and survival for patients whose tumors express NY-ESO-1 were not the result of increased cytotoxicity, but rather were mediated through immunological ...stimulator ... See full document

... because of insuffi- cient information. Titles and abstracts were examined at first to eliminate not applicable stud- ies, such as studies on animals or cell lines, reviews and studies about ... See full document

... Lung cancer is one of the most common human cancers and the leading cause of cancer-related deaths with non-small cell lung ... See full document

... However, in most of the studies, arterial and venous invasion has not been separately studied pathologically due to the inability in some cases to discriminate between arterial ... See full document

... as prognostic markers of 3-month survival after diagnosis of stage IV non-small cell lung cancer ...a cancer treatment center in southern ... See full document

... [3] in a study to understand the biologic process underlying the differentiation of reticulocytes to mature ...erythrocytes. The authors observed that maturing reticulocytes contained ... See full document

... redirect and reprogram patient T-cells have shown promising results in the treatment of acute lympho- blastic leukemia and non-Hodgkin’s ...with the ability to target ... See full document

... early-stage non-small-cell lung cancer (NSCLC) is considered a potentially curable disease following complete resection, patients have a wide spectrum of survival according to ... See full document

... Potential of POTEE as a Serologic Tumor Biomarker in NSCLC A ROC curve analysis was carried out to assess the value of POTEE in NSCLC ...reflect the sensitivity and ... See full document

... combination of LMR and MBR could predict prognosis in EGFR -mutant NSCLC patients receiving first-line ...PS, and a lower incidence of brain and distant ...tant role ... See full document

... considered the key molecule because it is the only member of the PA family shown to accelerate cell migration in ...vitro. In comparison, our IHC data demonstrated no ... See full document

... Firstly the increase in platelet count may promote tumor cells growth and ...(VEGF) and platelet- derived growth factor (PDGF), during blood clotting. The VEGF and PDGF fam- ily ... See full document

... level and treatment response ...patients and found to be only useful in patients with an increased pre-treatment level ...[29]. The levels of lactate dehydrogenase and ... See full document

... showed the strongest correlation with the positive DTC ...among the bone marrow- positive NSCLC patients, indicating a likely presence of tumor suppressor genes within this region ...[14]. ... See full document

... The prognostic predictive value of survivin expression and that of nuclear staining versus cytoplasmic staining in several malig- nancies, including NSCLC, have been ... See full document

... inflammation, cancer can induce local or systemic inflammation, which is mediated by activation of transcription factors and production of major inflammatory cyto- kines ...On the other ... See full document

... Correlate the inhibitor of gefitinib this inhibitor for signaling to increase ...grows. The patients who are affected by gefitinib are exposed to screening for identification of lung ... See full document

... predictors of outcome with geitinib in a phase III placebocontrolled study in advanced non-small-cell lung ...impact of induction chemotherapy ... See full document

... Akt and phospho-Akt (S473), clone D9E were from Cell Signaling Technology (CST); AXL (#AF154) and phospho-AXL (Y779) (#AF228) were from R&D Systems; GAPDH, clone 1D4 or #5174 was respectively ... See full document

... regarding the effects of PCI on toxicity and QOL in patients with ...because the related symptoms can be caused by many different ...dose and fractionation scheme (fraction size ... See full document